In a previous study, we reported that interleukin-4 production was reduced in spleen cells of mice administered 3,5,6,7,8,3′,4′-heptamethoxyflavone (HMF), which is a polymethoxyflavone found at high concentrations in the peel of various citrus fruits. In this study, we investigated the function of HMF on the growth of T cells cultured from the spleens of mice. HMF decreased the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) by anti-CD3/CD28 antibody-stimulated mouse spleen cells. HMF inhibited the activities of phosphodiesterase (PDE) enzymes prepared from bovine brain and human PDE4B and PDE3B enzymes. The cyclic AMP (cAMP) content in anti-CD3/CD28 antibody-stimulated spleen cells increased after HMF treatment in vitro. These results suggest that HMF inhibits T-cell growth and affects immune function via reduced PDE activity and increased cAMP content.

1.
Li S, Pan M-H, Lo C-Y, Tan D, Wang Y, Shahidi F, Ho C-T: Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones. J Funct Foods 2009;1:2-12.
2.
Amakura Y, Yoshimura M, Ouchi K, Okuyama S, Furukawa Y, Yoshida T: Characterization of constituents in the peel of Citrus kawachiensis (Kawachibankan). Biosci Biotechnol Biochem 2013;77:1977-1980.
3.
Nagase H, Omae N, Omori A, Nakagawasai O, Tadano T, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y: Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. Biochem Biophys Res Commun 2005;337:1330-1336.
4.
Nagase H, Yamakuni T, Matsuzaki K, Maruyama Y, Kasahara J, Hinohara Y, Kondo S, Mimaki Y, Sashida Y, Tank AW, Fukunaga K, Ohizumi Y: Mechanism of neurotrophic action of nobiletin in PC12D cells. Biochemistry 2005;44:13683-13691.
5.
Onozuka H, Nakajima A, Matsuzaki K, Shin RW, Ogino K, Saigusa D, Tetsu N, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y: Nobiletin, a citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther 2008;326:739-744.
6.
Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A, Mimaki Y, Sashida Y, Yamakuni T, Ohizumi Y, Fukunaga K: Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res 2009;1295:218-229.
7.
Yabuki Y, Ohizumi Y, Yokosuka A, Mimaki Y, Fukunaga K: Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. Neuroscience 2014;259:126-141.
8.
Furukawa Y, Okuyama S, Amakura Y, Watanabe S, Fukata T, Nakajima M, Yoshimura M, Yoshida T: Isolation and characterization of activators of ERK/MAPK from citrus plants. Int J Mol Sci 2012;13:1832-1845.
9.
Okuyama S, Fukata T, Nishigawa Y, Amakura Y, Yoshimura M, Yoshida T, Nakajima M, Furukawa Y: Citrus flavonoid improves MK-801-induced locomotive hyperactivity: possible relevance to schizophrenia. J Funct Foods 2013;5:2002-2006.
10.
Okuyama S, Miyoshi K, Tsumura Y, Amakura Y, Yoshimura M, Yoshida T, Nakajima M, Furukawa Y: 3,5,6,7,8,3′,4′-Heptamethoxyflavone, a citrus polymethoxylated flavone, attenuates inflammation in the mouse hippocampus. Brain Sci 2015;5:118-129.
11.
Okuyama S, Morita M, Miyoshi K, Nishigawa Y, Kaji M, Sawamoto A, Terugo T, Toyoda N, Makihata N, Amakura Y, Yoshimura M, Nakajima M, Furukawa Y: 3,5,6,7,8,3′,4′-Heptamethoxyflavone, a citrus flavonoid, on protection against memory impairment and neuronal cell death in a global cerebral ischemia mouse model. Neurochem Int 2014;70:30-38.
12.
Matsumoto C, Inoue H, Tominari T, Watanabe K, Hirata M, Miyaura C, Inada M: Heptamethoxyflavone, a citrus flavonoid, suppresses inflammatory osteoclastogenesis and alveolar bone resorption. Biosci Biotechnol Biochem 2015;79:155-158.
13.
Gell PGH, Coombs RRA: The classification of allergic reactions underlying disease; in Coombs RRA, Gell PGH (eds): Clinical Aspects of Immunology. Oxford, Blackwell Science, 1963.
14.
Wu LC, Scheerens H: Targeting IgE production in mice and humans. Curr Opin Immunol 2014;31:8-15.
15.
Nakajima M, Ogawa M, Amakura Y, Yoshimura M, Okuyama S, Furukawa Y: 3,5,6,7,8,3′,4′-Heptamethoxyflavone reduces interleukin-4 production in the spleen cells of mice. Biomed Res 2016;37:95-99.
16.
Okuyama S, Morita M, Miyoshi K, Nishigawa Y, Kaji M, Sawamoto A, Terugo T, Toyoda N, Makihata N, Amakura Y, Yoshimura M, Nakajima M, Furukawa Y: 3,5,6,7,8,3′,4′-Heptamethoxyflavone, a citrus flavonoid, on protection against memory impairment and neuronal cell death in a global cerebral ischemia mouse model. Neurochem Int 2014;70:30-38.
17.
Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A: Innate immune response in Th1- and Th2-dominant mouse strains. Shock 2004;22:460-466.
18.
Fernández-Ramos AA, Poindessous V, Marchetti-Laurent C, Pallet N, Loriot MA: The effect of immunosuppressive molecules on T-cell metabolic reprogramming. Biochimie 2016;127:23-36.
19.
Koda A, Yanagihara Y, Matsuura N: IPD-1151T: a prototype drug for IgE antibody synthesis modulation. Agents Actions Suppl 1991;34:369-378.
20.
Shioya T, Satake M, Sano M, Kagaya M, Watanabe A, Sato K, Ito T, Ito N, Sasaki M, Miura M: Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma. Eur J Clin Pharmacol 2002;58:171-176.
21.
Bender AT, Beavo JA: Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006;58:488-520.
22.
Shakur Y, Holst LS, Landstrom TR, Movsesian M, Degerman E, Manganiello V: Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family. Prog Nucleic Acid Res Mol Biol 2001;66:241-277.
23.
Yoshihara S, Fukuda H, Arisaka O: Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study. Arzneimittelforschung 2011;61:421-424.
24.
Ruppelt A, Mosenden R, Grönholm M, Aandahl EM, Tobin D, Carlson CR, Abrahamsen H, Herberg FW, Carpén O, Taskén K: Inhibition of T cell activation by cyclic adenosine 5′-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin. J Immunol 2007;179:5159-5168; erratum J Immunol 2011;186:7269-7271.
25.
Essayan DM: Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochem Pharmacol 1999;57:965-973.
26.
Palmer D, Maurice DH: Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues. Mol Pharmacol 2000;58:247-252.
27.
Okuyama S, Miyazaki K, Yamada R, Amakura Y, Yoshimura M, Sawamoto A, Nakajima M, Furukawa Y: Permeation of polymethoxyflavones into the mouse brain and their effect on MK-801-induced locomotive hyperactivity. Int J Mol Sci 2017;18: E489.
28.
Moore AR, Willoughby DA: The role of cAMP regulation in controlling inflammation. Clin Exp Immunol 1995;101:387-389.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.